Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02911363 · ClinicalTrials.gov registry record · NA

Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma

A NA study, sponsored by AdventHealth.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02911363: Completed NA study, sponsored by AdventHealth.

NCT02911363 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02911363, a NA study, has completed, sponsored by AdventHealth.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The main purpose of this study will be to two-fold; firstly to determine whether the use of a Captivator tissue cassette has an effect on the preservation of tissue histology (minimizing artifactual curling) , and secondly to determine whether the use of a intraprocedural cassette is practical. The investigators believe that this will greatly aid in elucidating the best technique for optimizing performance of EMR for esophageal lesions.

Primary Outcome

1\. Captivator tissue cassette vs. no cassette 1. Captivator tissue cassette with margin curling/artifact vs. Captivator tissue cassette without margin curling/artifact 2. No cassette with margin curling/artifact vs. no cassette without margin curling/artifact 3. Captivator tissue cassette with margin curling/artifact vs. No cassette with margin curling/artifact

Interventions

  • OTHER Standard of Care
  • DEVICE Captivator cassette

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2016-01
Est. Completion 2018-08
Phase NA
AdventHealth

95 total trials

What the finished NCT02911363 record still lists

NCT02911363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.

NCT02911363 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02911363 about?

NCT02911363 is a clinical study titled "Comparison of Captivator Tissue Cassettes vs. no Cassettes for Endoscopic Mucosal Resection in Esophageal Carcinoma". The main purpose of this study will be to two-fold; firstly to determine whether the use of a Captivator tissue cassette has an effect on the preservation of tissue histology (minimizing artifactual curling) , and secondly to determine whether the use of a intraprocedural cassette is practical. The ...

What is the current status of trial NCT02911363?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-01. Estimated completion is 2018-08.

What interventions are being tested in trial NCT02911363?

The interventions under investigation include: Standard of Care (OTHER), Captivator cassette (DEVICE).

Who is sponsoring clinical trial NCT02911363?

This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02911363's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02911363, the US trial registry maintained by the National Library of Medicine. NCT02911363 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.